Covid-19 Impact on Naloxone Market , Global Research Reports 2020-2021

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Naloxone Industry

1.7 COVID-19 Impact: Naloxone Market Trends

2 Global Naloxone Quarterly Market Size Analysis

2.1 Naloxone Business Impact Assessment - COVID-19

2.1.1 Global Naloxone Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Naloxone Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Naloxone Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Naloxone Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Naloxone Factory Price by Manufacturers

3.3 Location of Key Manufacturers Naloxone Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Naloxone Market

3.5 Key Manufacturers Naloxone Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Naloxone Segments, By Type

4.1 Introduction

1.4.1 Spray forms

1.4.2 Injectable forms

4.2 By Type, Global Naloxone Market Size, 2019-2021

4.2.1 By Type, Global Naloxone Market Size by Type, 2020-2021

4.2.2 By Type, Global Naloxone Price, 2020-2021

5 Impact of Covid-19 on Naloxone Segments, By Application

5.1 Overview

5.5.1 Opioid overdose

5.5.2 Preventing opioid abuse

5.2 By Application, Global Naloxone Market Size, 2019-2021

5.2.1 By Application, Global Naloxone Market Size by Application, 2019-2021

5.2.2 By Application, Global Naloxone Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 ADAPT Pharma

7.1.1 ADAPT Pharma Business Overview

7.1.2 ADAPT Pharma Naloxone Quarterly Production and Revenue, 2020

7.1.3 ADAPT Pharma Naloxone Product Introduction

7.1.4 ADAPT Pharma Response to COVID-19 and Related Developments

7.2 Amphastar Pharmaceuticals

7.2.1 Amphastar Pharmaceuticals Business Overview

7.2.2 Amphastar Pharmaceuticals Naloxone Quarterly Production and Revenue, 2020

7.2.3 Amphastar Pharmaceuticals Naloxone Product Introduction

7.2.4 Amphastar Pharmaceuticals Response to COVID-19 and Related Developments

7.3 Pfizer

7.3.1 Pfizer Business Overview

7.3.2 Pfizer Naloxone Quarterly Production and Revenue, 2020

7.3.3 Pfizer Naloxone Product Introduction

7.3.4 Pfizer Response to COVID-19 and Related Developments

7.4 kaleo

7.4.1 kaleo Business Overview

7.4.2 kaleo Naloxone Quarterly Production and Revenue, 2020

7.4.3 kaleo Naloxone Product Introduction

7.4.4 kaleo Response to COVID-19 and Related Developments

7.5 Sandoz

7.5.1 Sandoz Business Overview

7.5.2 Sandoz Naloxone Quarterly Production and Revenue, 2020

7.5.3 Sandoz Naloxone Product Introduction

7.5.4 Sandoz Response to COVID-19 and Related Developments

7.6 Amneal Pharmaceuticals

7.6.1 Amneal Pharmaceuticals Business Overview

7.6.2 Amneal Pharmaceuticals Naloxone Quarterly Production and Revenue, 2020

7.6.3 Amneal Pharmaceuticals Naloxone Product Introduction

7.6.4 Amneal Pharmaceuticals Response to COVID-19 and Related Developments

7.7 West Ward Pharmaceuticals

7.7.1 West Ward Pharmaceuticals Business Overview

7.7.2 West Ward Pharmaceuticals Naloxone Quarterly Production and Revenue, 2020

7.7.3 West Ward Pharmaceuticals Naloxone Product Introduction

7.7.4 West Ward Pharmaceuticals Response to COVID-19 and Related Developments

7.8 Mylan

7.8.1 Mylan Business Overview

7.8.2 Mylan Naloxone Quarterly Production and Revenue, 2020

7.8.3 Mylan Naloxone Product Introduction

7.8.4 Mylan Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Naloxone Supply Chain Analysis

8.1.1 Naloxone Supply Chain Analysis

8.1.2 Covid-19 Impact on Naloxone Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Naloxone Distribution Channels

8.2.2 Covid-19 Impact on Naloxone Distribution Channels

8.2.3 Naloxone Distributors

8.3 Naloxone Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Naloxone Assessment

Table 9. COVID-19 Impact: Naloxone Market Trends

Table 10. COVID-19 Impact Global Naloxone Market Size

Table 11. Global Naloxone Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)

Table 12. Global Naloxone Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)

Table 13. Global Naloxone Quarterly Market Size, 2020 (US$ Million) & (K Units)

Table 14. Global Naloxone Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Naloxone Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)

Table 16. Global Naloxone Market Growth Drivers

Table 17. Global Naloxone Market Restraints

Table 18. Global Naloxone Market Opportunities

Table 19. Global Naloxone Market Challenges

Table 20. Key Manufacturers Naloxone Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Naloxone Market Size, 2019 (K Units) & (US$ Million)

Table 22. Naloxone Factory Price by Manufacturers 2020 (USD/Unit)

Table 23. Location of Key Manufacturers Naloxone Manufacturing Plants

Table 24. Key Manufacturers Naloxone Market Served

Table 25. Date of Key Manufacturers Enter into Naloxone Market

Table 26. Key Manufacturers Naloxone Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Naloxone Market Size by Type, 2020, (US$ Million)

Table 29. Global Naloxone Market Size by Type, 2020 (K Units)

Table 30. Global Naloxone Price: by Type, 2020-2021 (USD/Unit)

Table 31. Global Naloxone Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Naloxone Market Size by Application, 2020-2021 (K Units)

Table 33. Global Naloxone Price: by Application, 2020-2021 (USD/Unit)

Table 34. Global Naloxone Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Naloxone Market Size by Region, 2019-2021 (K Units)

Table 36. By Country, North America Naloxone Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Naloxone Market Size, 2019-2021 (K Units)

Table 38. US Naloxone Market Size, 2019-2021 (US$ Million) & (K Units)

Table 39. Canada Naloxone Market Size, 2019-2021 (US$ Million) & (K Units)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Naloxone Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Naloxone Market Size, 2019-2021 (K Units)

Table 43. Germany Naloxone Market Size, 2019-2021 (US$ Million) & (K Units)

Table 44. France Naloxone Market Size, 2019-2021 (US$ Million) & (K Units)

Table 45. UK Naloxone Market Size, 2019-2021 (US$ Million) & (K Units)

Table 46. Italy Naloxone Market Size, 2019-2021 (US$ Million) & (K Units)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Naloxone Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Naloxone Market Size, 2019-2021 (K Units)

Table 50. China Naloxone Market Size, 2019-2021 (US$ Million) & (K Units)

Table 51. Japan Naloxone Market Size, 2019-2021 (US$ Million) & (K Units)

Table 52. South Korea Naloxone Market Size, 2019-2021 (US$ Million) & (K Units)

Table 53. India Naloxone Market Size, 2019-2021 (US$ Million) & (K Units)

Table 54. ASEAN Naloxone Market Size, 2019-2021 (US$ Million) & (K Units)

Table 55. Latin America Naloxone Market Size, 2019-2021 (US$ Million) & (K Units)

Table 56. Middle East and Africa Naloxone Market Size, 2019-2021 (US$ Million) & (K Units)

Table 57. ADAPT Pharma Business Overview

Table 58. ADAPT Pharma Naloxone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. ADAPT Pharma Naloxone Product

Table 60. ADAPT Pharma Response to COVID-19 and Related Developments

Table 61. Amphastar Pharmaceuticals Business Overview

Table 62. Amphastar Pharmaceuticals Naloxone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Amphastar Pharmaceuticals Naloxone Product

Table 64. Amphastar Pharmaceuticals Response to COVID-19 and Related Developments

Table 65. Pfizer Business Overview

Table 66. Pfizer Naloxone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Pfizer Naloxone Product

Table 68. Pfizer Response to COVID-19 and Related Developments

Table 69. kaleo Business Overview

Table 70. kaleo Naloxone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. kaleo Naloxone Product

Table 72. kaleo Response to COVID-19 and Related Developments

Table 73. Sandoz Business Overview

Table 74. Sandoz Naloxone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Sandoz Naloxone Product

Table 76. Sandoz Response to COVID-19 and Related Developments

Table 77. Amneal Pharmaceuticals Business Overview

Table 78. Amneal Pharmaceuticals Naloxone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. Amneal Pharmaceuticals Naloxone Product

Table 80. Amneal Pharmaceuticals Response to COVID-19 and Related Developments

Table 81. West Ward Pharmaceuticals Business Overview

Table 82. West Ward Pharmaceuticals Naloxone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. West Ward Pharmaceuticals Naloxone Product

Table 84. West Ward Pharmaceuticals Response to COVID-19 and Related Developments

Table 85. Mylan Business Overview

Table 86. Mylan Naloxone Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Mylan Naloxone Product

Table 88. Mylan Response to COVID-19 and Related Developments

Table 89. Naloxone Distributors List

Table 90. Naloxone Customers List

Table 91. Covid-19 Impact on Naloxone Customers

List of Figures

Figure 1. Naloxone Product Picture

Figure 2. Naloxone Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Naloxone Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Naloxone Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Naloxone Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Naloxone Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Naloxone Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Naloxone Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Naloxone Market Size Market Share, 2019-2021